CCR8

CCR8 분자 정보

영어 이름C-C chemokine receptor type 8시판 약물 수0
임상 약물 수21표적 별명Chemokine (C-C) Receptor 8,CC Chemokine Receptor 8,CDw198 Antigen,C-C CKR-8,CC-CKR-8,CCR-8,CMKBRL2,C-C Motif Chemokine Receptor 8,CC chemokine receptor CHEMR1,C-C chemokine receptor type 8,Chemokine (C-C Motif) Receptor 8,C-C Chemokine Receptor Type 8,CC Chemokine Receptor CHEMR1,Chemokine Receptor-Like 1,Chemokine (C-C) Receptor-Like 2,CC-Chemokine Receptor Chemr1,CD_antigen=CDw198,Chemokine receptor-like 1,CKRL1,CKR-L1,CMKBR8,GPRCY6,GPR-CY6,TER1,CDw198,CY6
최고 연구 개발 단계Phase 3 Clinical
영어 이름C-C chemokine receptor type 8
표적 별명Chemokine (C-C) Receptor 8,CC Chemokine Receptor 8,CDw198 Antigen,C-C CKR-8,CC-CKR-8,CCR-8,CMKBRL2,C-C Motif Chemokine Receptor 8,CC chemokine receptor CHEMR1,C-C chemokine receptor type 8,Chemokine (C-C Motif) Receptor 8,C-C Chemokine Receptor Type 8,CC Chemokine Receptor CHEMR1,Chemokine Receptor-Like 1,Chemokine (C-C) Receptor-Like 2,CC-Chemokine Receptor Chemr1,CD_antigen=CDw198,Chemokine receptor-like 1,CKRL1,CKR-L1,CMKBR8,GPRCY6,GPR-CY6,TER1,CDw198,CY6
시판 약물 수0
임상 약물 수21
최고 연구 개발 단계Phase 3 Clinical

CCR8 제품 목록

  • 속성

    Protein (8)Cell (1)Antibody (1)

  • 제품 라이브러리

    온라인 (10)

  • Human (7)Mouse (2)Rhesus macaque (1)

  • 태그

    His Tag & Flag Tag (1)- (7)Flag Tag & His Tag & Strep Tag (2)

  • 마커

    Unconjugated (7)- (1)Biotin-labeled (2)

CCR8분자 배경

CCR8 is a G protein-coupled chemokine receptor expressed on regulatory T cells and in tumor microenvironments, mediating chemotaxis, immune regulation, and pathological processes like inflammation or cancer progression. The unconjugated anti-human CCR8 antibody enables specific detection of human CCR8.

CCR8분자 별명

CC chemokine receptor 8,CDw198,ChemR1,CKRL1,CKR-L1,CKRL1,CY6,GPRCL1,GPRCY6,GPR-CY6,TER-1

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
CCR8 mAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
CCR8 mAb - 02LeadMonoclonalHumanized MouseSolid TumorSolid tumor
CCR8 mAb - 03PCCMonoclonalHumanized MouseSolid TumorSolid tumor

라이선싱 협력

프로젝트 이름약물 유형치료 영역적응증단계권리 지역
CCR8 Humanized AntibodyBispecific antibodyOncology/CancerSolid TumorPreclinicalGlobal

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CafelkibartLM-108Phase 3 ClinicalLaNova Medicines LtdCarcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
ImzokitugBMS-986340; ONO-7427Phase 2 ClinicalEeig Bristol-Myers Squibb Manufacturing Company Bristol-Myers Squibb SrlCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal Neoplasms; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms
상세
TAK- 188TAK- 188Phase 2 ClinicalTakeda Pharmaceutical Co LtdSolid tumours
상세
QLP2117QLP2117; QLP-2117Phase 2 ClinicalQilu Pharmaceutical Co LtdNeoplasms; Solid tumours
상세
DT-7012DT-7012Phase 2 ClinicalDomain Therapeutics SALymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasms; Sezary Syndrome; Solid tumours
상세
S-531011S-531011Phase 2 ClinicalShionogi IncSolid tumours
상세
IPG-7236IPG-7236Phase 2 ClinicalNanjing Immunophage Biotech Co LtdBreast Neoplasms; Dermatitis, Atopic; Solid tumours
상세
anti-CCR8 antibody (Bristol-Myers Squibb)Phase 1 ClinicalBristol-Myers Squibb CompanySolid tumours
상세
PSB-114PSB-114Phase 1 ClinicalQilu Puget Sound Biotherapeutics CorpNeoplasms
상세
BAY-3375968BAY-3375968Phase 1 ClinicalBayer AGNeoplasms; Solid tumours
상세
ICP-B05ICPB05; CM-369Phase 1 ClinicalInnoCare Pharma Ltd, Keymed Biosciences Co LtdHematologic Neoplasms; Solid tumours
상세
HBM-1022HBM-1022Phase 1 ClinicalHarbour BiomedNeoplasms
상세
DenikitugJTX-1811; GS-1811Phase 1 ClinicalJounce Therapeutics IncSolid tumours
상세
TagmokitugCHS-114; SRF-114Phase 1 ClinicalSurface Oncology IncNeoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
TQB-6457TQB-6457; TQB6457Phase 1 ClinicalShanghai Chia Tai Tianqing Pharmaceutical Technology Development Co LtdNeoplasms
상세
KYS-2301KYS2301; KYS-2301Phase 1 ClinicalJiangsu Kanion Pharmaceutical Co LtdDermatitis, Atopic
상세
AMG-355AMG 355; AMG-355Phase 1 ClinicalAmgen IncSolid tumours
상세
HC-006HC-006; HC006Phase 1 ClinicalShanghai Hongcheng Pharmaceutical Co LtdNeoplasms; Solid tumours
상세
BGB-A3055BGB-A3055Phase 1 ClinicalBeOne Medicines LtdSolid tumours
상세
ABBV-514ABBV-514Phase 1 ClinicalAbbvie IncCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cystadenocarcinoma, Serous; Ovarian Neoplasms; Pancreatic Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
상세
IPGA-05IPGA-05; IPG0521; IPG-0521Phase 1 ClinicalNanjing Immunophage Biotech Co LtdAutoimmune Diseases; Immunoglobulin G4-Related Disease; Solid tumours
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호